Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Prostatic Neoplasms × Hydroxyethyl Starch Derivatives × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Rectal Neoplasms 1 Prostatic Neoplasms 1 Diverticulitis 1 Crohn Disease 1 Colonic Polyps 1 Colonic Neoplasms 1 Colitis, Ulcerative 1

Interventions

Docetaxel 144 Prednisone 108 Leuprolide 81 enzalutamide 69 Radiotherapy 69 bicalutamide 68 Goserelin 66 Abiraterone Acetate 65 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 47 Zoledronic Acid 36 Magnetic Resonance Spectroscopy 34 Estramustine 28 abiraterone 27 gallium 68 PSMA-11 26 apalutamide 26 Flutamide 26 radium Ra 223 dichloride 24 Radiosurgery 22 Gonadotropin-Releasing Hormone 21 Dutasteride 20 Androgen Antagonists 20 sipuleucel-T 19 cabazitaxel 19 Surveys and Questionnaires 18 Radiation 18 Exercise 17 Brachytherapy 17 luprolide acetate gel depot 16 Triptorelin Pamoate 16 Prednisolone 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01486563 2013-09-17

VORA

Regional Hospital Holstebro

Phase 4 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡